A Randomised, Double-blind Placebo-controlled Study to Assess the Safety of Four Single Ascending Doses of HF1020 in Healthy Male Subjects.

Trial Profile

A Randomised, Double-blind Placebo-controlled Study to Assess the Safety of Four Single Ascending Doses of HF1020 in Healthy Male Subjects.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 28 Oct 2011

At a glance

  • Drugs HF 1020 (Primary)
  • Indications Allergic asthma; Type 1 diabetes mellitus
  • Focus Adverse reactions
  • Most Recent Events

    • 01 Sep 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top